MERCADOLIBRE INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MERCADOLIBRE INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.89B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $20.78B | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | $4.26B | Feb 23, 2024 |
| FY2023 | Sep 30, 2023 | $3.76B | Feb 23, 2024 |
| FY2023 | Jun 30, 2023 | $3.42B | Feb 23, 2024 |
| FY2023 | Mar 31, 2023 | $3.04B | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | $3.00B | Feb 23, 2024 |
| FY2023 | Sep 30, 2022 | $2.69B | Feb 23, 2024 |
| FY2023 | Jun 30, 2022 | $2.60B | Feb 23, 2024 |
| FY2023 | Mar 31, 2022 | $2.25B | Feb 23, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.34B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $15.14B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $10.49B | Feb 25, 2026 |
| FY2022 | Dec 31, 2022 | $3.00B | Feb 24, 2023 |
| FY2022 | Sep 30, 2022 | $2.69B | Feb 24, 2023 |
| FY2022 | Jun 30, 2022 | $2.60B | Feb 24, 2023 |
| FY2022 | Mar 31, 2022 | $2.25B | Feb 24, 2023 |
| FY2022 | Dec 31, 2021 | $2.13B | Feb 24, 2023 |
| FY2022 | Sep 30, 2021 | $1.86B | Feb 24, 2023 |
| FY2022 | Jun 30, 2021 | $1.70B | Feb 24, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.86B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $9.58B | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | $1.96B | Feb 23, 2024 |
| FY2023 | Sep 30, 2023 | $2.00B | Feb 23, 2024 |
| FY2023 | Jun 30, 2023 | $1.72B | Feb 23, 2024 |
| FY2023 | Mar 31, 2023 | $1.54B | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | $1.46B | Feb 23, 2024 |
| FY2023 | Sep 30, 2022 | $1.35B | Feb 23, 2024 |
| FY2023 | Jun 30, 2022 | $1.28B | Feb 23, 2024 |
| FY2023 | Mar 31, 2022 | $1.07B | Feb 23, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.00B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.91B | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | $165.00M | Feb 23, 2024 |
| FY2023 | Sep 30, 2023 | $359.00M | Feb 23, 2024 |
| FY2023 | Jun 30, 2023 | $262.00M | Feb 23, 2024 |
| FY2023 | Mar 31, 2023 | $201.00M | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | $165.00M | Feb 23, 2024 |
| FY2023 | Sep 30, 2022 | $129.00M | Feb 23, 2024 |
| FY2023 | Jun 30, 2022 | $123.00M | Feb 23, 2024 |
| FY2023 | Mar 31, 2022 | $65.00M | Feb 23, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.20B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.63B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.21B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.07B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $441.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $128.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | ($153.16M) | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | ($69.48M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $56.27M | Dec 23, 2020 |
| FY2018 | Dec 31, 2016 | $181.06M | Feb 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.27B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.93B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.83B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $590.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $353.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $223.81M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $146.27M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $127.16M | Dec 23, 2020 |
| FY2018 | Dec 31, 2016 | $98.48M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.12B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $7.92B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $5.14B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $2.94B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $965.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.18B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $451.09M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $230.91M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $269.01M | Dec 23, 2020 |
| FY2018 | Dec 31, 2016 | $190.26M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $509.00M | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | $454.00M | Feb 23, 2024 |
| FY2023 | Dec 31, 2021 | $573.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $247.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $136.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $93.14M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $55.16M | Dec 23, 2020 |
| FY2018 | Dec 31, 2016 | $68.53M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $39.15M | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $34.43M | Feb 24, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.67B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $25.20B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $17.61B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $13.74B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $10.10B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $6.53B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $4.78B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.24B | Dec 23, 2020 |
| FY2018 | Dec 31, 2017 | $1.67B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.37B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.92B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $20.85B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $14.54B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $11.91B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $8.57B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $4.87B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $2.70B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.90B | Dec 23, 2020 |
| FY2018 | Dec 31, 2017 | $1.35B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $938.58M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.75B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.35B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $3.07B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $1.83B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $1.53B | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $1.65B | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $1.98B | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $336.70M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $325.78M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $428.85M | Dec 23, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $163.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $149.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $163.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $153.00M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $148.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $85.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $87.61M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $88.88M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $92.28M | Dec 23, 2020 |
| FY2018 | Dec 31, 2016 | $91.80M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.81B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.81B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.90B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $913.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $397.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $314.12M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $322.59M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $503.43M | Dec 23, 2020 |
| FY2018 | Dec 31, 2017 | $537.93M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $550.64M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.67B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.64B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.56B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.91B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.59B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.86B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.38B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $440.33M | Dec 23, 2020 |
| FY2018 | Dec 31, 2017 | $388.26M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $234.14M | Feb 23, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.19B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.72B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $4.50B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $4.76B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.52B | Feb 24, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 37 | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | 3 | Feb 23, 2024 |
| FY2023 | Sep 30, 2023 | 7 | Feb 23, 2024 |
| FY2023 | Jun 30, 2023 | 5 | Feb 23, 2024 |
| FY2023 | Mar 31, 2023 | 4 | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | 3 | Feb 23, 2024 |
| FY2023 | Sep 30, 2022 | 2 | Feb 23, 2024 |
| FY2023 | Jun 30, 2022 | 2 | Feb 23, 2024 |
| FY2023 | Mar 31, 2022 | 1 | Feb 23, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 39 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 37 | Feb 25, 2026 |
| FY2023 | Dec 31, 2023 | 3 | Feb 23, 2024 |
| FY2023 | Sep 30, 2023 | 7 | Feb 23, 2024 |
| FY2023 | Jun 30, 2023 | 5 | Feb 23, 2024 |
| FY2023 | Mar 31, 2023 | 3 | Feb 23, 2024 |
| FY2023 | Dec 31, 2022 | 3 | Feb 23, 2024 |
| FY2023 | Sep 30, 2022 | 2 | Feb 23, 2024 |
| FY2023 | Jun 30, 2022 | 2 | Feb 23, 2024 |
| FY2023 | Mar 31, 2022 | 1 | Feb 23, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 50.70M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 50.70M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 50.70M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 50.26M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 50.42M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 49.87M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 49.71M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 45.20M | Dec 23, 2020 |
| FY2018 | Dec 31, 2017 | 44.16M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 44.16M | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2018 | $6.62M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $26.50M | Dec 23, 2020 |
| FY2018 | Dec 31, 2016 | $24.42M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $20.97M | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $28.30M | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $23.75M | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $17.97M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $10.59M | Mar 3, 2014 |